Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed plus Poliovirus Vaccine Inactivated (Human Diploid Cell) - Repevax -- Product Record

dTpa-IPV booster/Sanofi

    Nomenclature:
      dTpa-IPV booster/Sanofi [BIO]
      Repevax [TR]
      Diphtheria, Tetanus, Pertussis (Acellular, Component) and Poliomyelitis (Inactivated) Vaccine, adjuvanted. [UK]
      Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed plus Poliovirus Vaccine Inactivated (Human Diploid Cell) [SY]

    FDA Class:  Biologic BLA

Index Terms:

  • Product Class Index:
      biopharmaceutical products
      vaccines, bacterial
      vaccines, combination
      vaccines, toxoids (inactivated toxins)
      vaccines, viral
  • Biological Index:
      adw, hepatitis B virus subtype
      bacterial culture <!-- bacterialculture -->
      Bordetella pertussis
      Clostridium tetani
      Corynebacterium diphtheriae
      vegetable oil extraction
  • Chemical Index:
      2-phenoxyethanol
      accelerated approval (based on surrogate endpoints) (FDAapproved)
      aluminum phosphate
      Diphtheria Toxoid
      filamentous hemagglutinin (FHA), Bordetella pertussis
      implants
      neomycin
      pertactin (69 kDa protein)
      pertussis toxin (PT)
      polymyxin
      polymyxin
      polysorbate 80 (Tween 80)
      streptolysin O
      Tetanus Toxoid
      Water for Injection
  • Source/Host/Expression System: Bacterial micbac monkey kidney mamprimemonkkidney
  • Regulatory/Status Index:
      North American coral snake
      EU200 Currently Approved in EU
      UM999 Not Available/Not Marketed in US
      US000 never filed/no plans
      EM001 Marketed Product in EU